$CTHP’s On the Grill But Who’s Cooking?
August 26th, 2009 at 11:56 am Posted by The Dean
The Dean’s been taking a good look around China and is impressed with how fast cities seem to be growing. With the global market expanding, and with countries like China, India and Russia quickly developing, The Dean believes the amount of money spent on health care and drugs will quickly GROW too.
IMS Health issued a report that said the global market for cancer drugs will EXPAND twice as fast as all other drug markets. As if the success of his Ivy League Stock Picks aren’t enough, The Dean is always pleased with facts that make companies like $CTHP tasty.
$CTHP is developing an array of cancer fighting drugs in a market expected to grow 12% to 15% to $80 billion, while the overall drug market expects growth of at least 6.4%.
The Dean thinks that many companies like $CTHP and partner NanoTherapies experience lag time because of the essential FDA approval process in the United States. Of course, that’s what gives $CTHP the potential to grow.
In his search to bring the CollegeStock Community relevant and fresh content, The Dean has found that many middle-of-the-road pharma companies are joining forces to make it happen.
In fact, Xconomy released an article today that suggests that pharmaceutical companies like Cadence Pharmaceuticals (NASDAQ: CADX) and Somaxon (NASDAQ: SOMX) are looking to retool existing drugs with new therapies and advancements in medicine. The Dean thinks this is increasingly common with cancer drug development which means $CTHP could be on the Big Pharma RADAR.
This article also mentions that many pharmaceutical companies like La Jolla Pharmaceuticals (NASDAQ: LJPC) are fighting for survival and NEED to merge with newer companies with fresh technologies and drugs in their pipelines.
This is why The Dean thinks $CTHP‘s potential lays in NanoTherapies exclusive rights to various technologies that treat and detect different types of common cancers. One of their PATENTS is for the NanoJacket technology which is said to make $CTHP‘s FOUR cancer fighting drugs last longer and are 7 TIMES more effective.
The Dean thinks $CTHP sounds NEW and FRESH enough to EAT; it’s just a matter of which Big Pharma will be in the kitchen.
Sign up to become The Dean’s newest Honors Student and receive access to The Dean’s Ivy League Stock Picks before the rest of the CollegeStock Community.
The Dean is so accessible that you can even connect with him by texting ‘thedean’ to 69302 on your wireless phone. TRY IT TODAY!
been holding over .20 for 3 weeks.
sounds tasty! vral made me good money today Dean. Honors Class all the way to the bank.
Have made over 20 % on cthp this week alone
Thanks
I have eyed on the $CTHP since long as I know developing countries will have more and more demand for Cancer relted drugs and $CTHP producys are having good market share. No doubt $CTHP’s colobaration partners are good to have. Definately I have invested and got good retuns in past.